Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)

China flag China · Delayed Price · Currency is CNY
12.40
-0.32 (-2.52%)
Feb 28, 2025, 2:45 PM CST
-11.74%
Market Cap 20.07B
Revenue (ttm) 3.88B
Net Income (ttm) -422.97M
Shares Out 1.62B
EPS (ttm) -0.26
PE Ratio n/a
Forward PE 22.65
Dividend 0.10 (0.79%)
Ex-Dividend Date n/a
Volume 7,025,087
Average Volume 9,912,376
Open 12.66
Previous Close 12.72
Day's Range 12.38 - 12.75
52-Week Range 10.45 - 16.01
Beta 0.53
RSI 33.53
Earnings Date Apr 29, 2025

About SHA:603707

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. The company provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, fulvestrant, doxercalciferol, milrinone lactate, fondaparinux sodium, phenylephrine, gemcitabine, levoleucovorin, carboplatin, cytarabine, bleomycin, topotecan hydrochloride, bendamustine HCL, bortezomib, clofarabine, busulfan, dactinomycin, azacitidine, mycophenolate mofetil, tige... [Read more]

Sector Healthcare
Founded 2000
Employees 1,451
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603707
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.